RCM
NEO icon

Raleigh Capital Management’s NeoGenomics NEO Stock Holding History

Raleigh Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-191
Closed -$2.35K – 1147
2023
Q3 		$2.35K Hold
191
– – ﹤0.01% 763
2023
Q2 		$3.07K Buy
+191
New +$3.15K ﹤0.01% 705

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Raleigh Capital Management's NEO Position: Q4 2023 in Review

Raleigh Capital Management sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 191 shares — an estimated $2.35K sold.

Raleigh Capital Management first reported a position in NEO in Q2 2023 and held it in 2 quarters. The position peaked at $3.07K in Q2 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Raleigh Capital Management reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • Raleigh Capital Management sold 191 NeoGenomics shares in Q4 2023, an estimated $2.35K.
  • Raleigh Capital Management first reported a position in NeoGenomics in Q2 2023 and held it in 2 quarters.
  • Raleigh Capital Management's NeoGenomics position peaked at $3.07K in Q2 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Raleigh Capital Management's 13F filing for Q4 2023, filed 21 Feb 2024.